Literature DB >> 11849049

Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation.

Heather E Kleiner1, Suryanarayana V Vulimiri, Melissa J Reed, Ann Uberecken, John DiGiovanni.   

Abstract

The current study was designed to determine the mechanistic basis for differences in the effects of naturally occurring furanocoumarins on skin tumor initiation by 7,12-dimethylbenz[a]anthracene (DMBA). Female SENCAR mice were pretreated topically with bergamottin, imperatorin, or isopimpinellin (100-3200 nmol), 7,8-benzoflavone (7,8-BF, 5-40 nmol, a known inhibitor of DMBA skin carcinogenesis in mice), or acetone (vehicle control) 5 min prior to topical treatment with DMBA (10 nmol). Imperatorin, isopimpinellin, and 7,8-BF, but not bergamottin, significantly blocked total DMBA-DNA adduct formation. HPLC analysis of DNA adducts revealed that bergamottin preferentially inhibited formation of anti-DMBA diol-epoxide (DMBADE) derived DNA adducts, imperatorin, and isopimpinellin inhibited both anti- and syn- derived adducts, whereas 7,8-BF showed some selectivity for reduction of syn-DMBADE-DNA adducts. Mouse embryo fibroblast C3H/10T1/2 (10T1/2) cells, and mouse hepatoma-derived 1c1c7 (Hepa-1) cells, which preferentially express P450 1b1 and P450 1a1, respectively, were co-incubated with 2 microM bergamottin, imperatorin, isopimpinellin, and 7,8-BF, and with DMBA (2 microM). Hepa-1 cells (P450 1a1) formed mainly anti-DMBADE-DNA adducts. In contrast, 10T1/2 cells (P450 1b1) formed mainly syn-DMBADE-DNA adducts. Bergamottin inhibited DMBA metabolism to DMBA-3,4-diol and blocked DNA adduct formation in Hepa-1 cells, but had little effect in 10T1/2 cells. In contrast, 7,8-BF completely blocked DMBA metabolism and DNA adduct formation in 10T1/2 cells, but had little effect in Hepa-1 cells. Imperatorin and isopimpinellin inhibited DMBA bioactivation in both cell lines. These results indicate that bergamottin is a more selective inhibitor of P450 1a1 and overall a less effective inhibitor of the metabolic activation of DMBA in mouse epidermis. In contrast, imperatorin, isopimpinellin, and especially 7,8-BF, which block metabolic activation of DMBA in mouse epidermis, appear more selective for P450 1b1. On the basis of our studies using 10T1/2 cells and Hepa-1 cells, it appears that P450 1a1 is primarily responsible for converting DMBA-3,4-diol to anti-DMBADE, whereas P450 1b1 is primarily responsible for converting DMBA-3,4-diol to syn-DMBADE. These data demonstrate the role of P450 1a1 and 1b1 in the metabolic activation of DMBA in mouse epidermis and provide a mechanistic explanation for the differential effects of naturally occurring furanocoumarins (and 7,8-BF) on polycyclic aromatic hydrocarbon skin carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849049     DOI: 10.1021/tx010151v

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  25 in total

1.  Contamination of deconjugation enzymes derived from Helix pomatia with the plant bioactive compounds 3,3'-diindolylmethane, 5-methoxypsoralen, and 8-methoxypsoralen.

Authors:  Cheryl E Ainslie-Waldman; Scott W Simpkins; Pramod Upadhyaya; Steven G Carmella; Stephen S Hecht; Sabrina P Trudo
Journal:  Food Chem Toxicol       Date:  2013-08-30       Impact factor: 6.023

2.  Effects of isoimperatorin on proliferation and apoptosis of human gastric carcinoma cells.

Authors:  Hai-Bo Yang; Hui-Ru Gao; Yuan-Jing Ren; Fei-Xiang Fang; Hong-Tao Tian; Zhen-Jiang Gao; Wei Song; Shao-Min Huang; An-Fang Zhao
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

3.  Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice.

Authors:  Heather E Kleiner; Xiaojun Xia; Junichiro Sonoda; Jun Zhang; Elizabeth Pontius; Jane Abey; Ronald M Evans; David D Moore; John DiGiovanni
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-15       Impact factor: 4.219

4.  Bergamottin, a natural furanocoumarin abundantly present in grapefruit juice, suppresses the invasiveness of human glioma cells via inactivation of Rac1 signaling.

Authors:  Wenzheng Luo; Zhenyu Song; Hongwei Sun; Junxin Liang; Shanshan Zhao
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

5.  Antiproliferative effect of gynura procumbens (lour.) Merr. Leaves etanolic extract on 7,12-dimethylbenz(a)antracene induced male rat liver.

Authors:  Fithriyatun Nisa; Adam Hermawan; Retno Murwanti; Edy Meiyanto
Journal:  Adv Pharm Bull       Date:  2012-04-15

Review 6.  Potential role of CYP1B1 in the development and treatment of metabolic diseases.

Authors:  Fei Li; Weifeng Zhu; Frank J Gonzalez
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

7.  CCAAT/ enhancer-binding protein β activation by capsaicin contributes to the regulation of CYP1A1 expression, mediated by the aryl hydrocarbon receptor.

Authors:  Eun Hee Han; Yong Pil Hwang; Hyung Gyun Kim; Jai Ho Choi; Bong Hwan Park; Gye Yong Song; Gye Won Lee; Tae Cheon Jeong; Hye Gwang Jeong
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

8.  Regio- and stereoselective metabolism of 7,12-dimethylbenz[a]anthracene by Mycobacterium vanbaalenii PYR-1.

Authors:  Joanna D Moody; Peter P Fu; James P Freeman; Carl E Cerniglia
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

9.  Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene.

Authors:  Zhipei Liu; Manfred Hergenhahn; Heinz H Schmeiser; Gerald N Wogan; Amanda Hong; Monica Hollstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

10.  Differential effects of several phytochemicals and their derivatives on murine keratinocytes in vitro and in vivo: implications for skin cancer prevention.

Authors:  Magdalena C Kowalczyk; Zbigniew Walaszek; Piotr Kowalczyk; Tatsuya Kinjo; Margaret Hanausek; Thomas J Slaga
Journal:  Carcinogenesis       Date:  2009-03-27       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.